{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:07:45Z","timestamp":1793030865752,"version":"4.5.0"},"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"publisher","award":["2037E"],"award-info":[{"award-number":["2037E"]}],"id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research Board","award":["HRA-PHR-2015-1088"],"award-info":[{"award-number":["HRA-PHR-2015-1088"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232086","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T19:19:11Z","timestamp":1589483951000},"page":"e0232086","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":252,"title":["Retention of patients in opioid substitution treatment: A systematic review"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-6732","authenticated-orcid":true,"given":"Aisling M\u00e1ire","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-0046","authenticated-orcid":true,"given":"Fiona","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"12","key":"pone.0232086.ref001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","year":"2018","journal-title":"The lancet Psychiatry"},{"issue":"1","key":"pone.0232086.ref002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"L Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"pone.0232086.ref003","article-title":"Medication Treatment of Opioid Use Disorder","author":"J Bell","year":"2019","journal-title":"Biological psychiatry"},{"issue":"7773","key":"pone.0232086.ref004","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/d41586-019-02682-6","article-title":"Opioids by the numbers","volume":"573","author":"L Drew","year":"2019","journal-title":"Nature"},{"issue":"11","key":"pone.0232086.ref005","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"AL Stotts","year":"2009","journal-title":"Expert opinion on pharmacotherapy"},{"key":"pone.0232086.ref006","doi-asserted-by":"crossref","first-page":"107609","DOI":"10.1016\/j.neuropharm.2019.04.015","article-title":"Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine","volume":"158","author":"CJ Jordan","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"pone.0232086.ref007","first-page":"Cd002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"RP Mattick","year":"2009","journal-title":"The Cochrane database of systematic reviews"},{"issue":"2","key":"pone.0232086.ref008","first-page":"Cd002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"RP Mattick","year":"2014","journal-title":"The Cochrane database of systematic reviews"},{"issue":"9","key":"pone.0232086.ref009","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"P Lawrinson","year":"2008","journal-title":"Addiction"},{"issue":"9148","key":"pone.0232086.ref010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"J Ward","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"1\u20132","key":"pone.0232086.ref011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"L Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"pone.0232086.ref012","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","article-title":"Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study","volume":"41","author":"G Cousins","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"pone.0232086.ref013","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"R Cornish","year":"2010","journal-title":"Bmj"},{"issue":"10","key":"pone.0232086.ref014","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","volume":"2","author":"J Kimber","year":"2015","journal-title":"The lancet Psychiatry"},{"key":"pone.0232086.ref015","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"L Sordo","year":"2017","journal-title":"Bmj"},{"issue":"6","key":"pone.0232086.ref016","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006\u201310","volume":"110","author":"E Evans","year":"2015","journal-title":"Addiction"},{"issue":"3","key":"pone.0232086.ref017","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","article-title":"Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine","volume":"13","author":"HG Kress","year":"2009","journal-title":"European journal of pain (London, England)"},{"issue":"1","key":"pone.0232086.ref018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study","volume":"111","author":"G Cousins","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"pone.0232086.ref019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"C Timko","year":"2016","journal-title":"J Addict Dis"},{"issue":"4","key":"pone.0232086.ref020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"L Amato","year":"2005","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"pone.0232086.ref021","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1345\/aph.1G276","article-title":"Role of buprenorphine in the management of heroin addiction","volume":"40","author":"S Sung","year":"2006","journal-title":"The Annals of pharmacotherapy"},{"issue":"1","key":"pone.0232086.ref022","first-page":"Cd007775","article-title":"Pharmacological therapies for maintenance treatments of opium dependence","author":"A Rahimi-Movaghar","year":"2013","journal-title":"The Cochrane database of systematic reviews"},{"issue":"8","key":"pone.0232086.ref023","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","article-title":"Drop-out from addiction treatment: a systematic review of risk factors","volume":"33","author":"HH Brorson","year":"2013","journal-title":"Clinical psychology review"},{"issue":"1","key":"pone.0232086.ref024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addbeh.2013.09.001","article-title":"Retention in methadone maintenance treatment in mainland China, 2004\u20132012: a literature review","volume":"39","author":"K Zhou","year":"2014","journal-title":"Addict Behav"},{"issue":"3","key":"pone.0232086.ref025","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.9778\/cmajo.20140089","article-title":"Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis","volume":"3","author":"M Bawor","year":"2015","journal-title":"CMAJ open"},{"issue":"7","key":"pone.0232086.ref026","doi-asserted-by":"crossref","first-page":"e68906","DOI":"10.1371\/journal.pone.0068906","article-title":"Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis","volume":"8","author":"L Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"pone.0232086.ref027","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS medicine"},{"issue":"5","key":"pone.0232086.ref028","first-page":"Cd011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"S Nielsen","year":"2016","journal-title":"The Cochrane database of systematic reviews"},{"key":"pone.0232086.ref029","volume-title":"A production from the ESRC Methods Programme","author":"J Popay","year":"2006"},{"issue":"Suppl 1","key":"pone.0232086.ref030","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1111\/dar.12608","article-title":"Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies","volume":"37","author":"L Wiessing","year":"2018","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"pone.0232086.ref031","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drugalcdep.2010.09.024","article-title":"Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial","volume":"115","author":"MC Chawarski","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0232086.ref032","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijpp.12049","article-title":"Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial","volume":"22","author":"M Jaffray","year":"2014","journal-title":"The International journal of pharmacy practice"},{"issue":"1","key":"pone.0232086.ref033","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsat.2013.08.012","article-title":"Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment","volume":"46","author":"LA Marsch","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"pone.0232086.ref034","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"RP Schwartz","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"pone.0232086.ref035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/02791072.2009.10400535","article-title":"Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome","volume":"41","author":"Y Abramsohn","year":"2009","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"pone.0232086.ref036","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/02791072.2013.825032","article-title":"Methadone maintenance treatment experience in Macao\u2014prospective follow-up for initial 4.5 years","volume":"45","author":"M Adelson","year":"2013","journal-title":"J Psychoactive Drugs"},{"key":"pone.0232086.ref037","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2018.08.024","article-title":"Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets","volume":"193","author":"S Amiri","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"pone.0232086.ref038","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.3390\/ijerph6112822","article-title":"Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study","volume":"6","author":"M Astals","year":"2009","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"pone.0232086.ref039","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"CJ Banta-Green","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"pone.0232086.ref040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: outcomes at year 7","volume":"12","author":"Bhatraju EP G","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"pone.0232086.ref041","first-page":"E739","article-title":"Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment","volume":"16","author":"V Bounes","year":"2013","journal-title":"Pain physician"},{"issue":"3","key":"pone.0232086.ref042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The impact of benzodiazepine use on methadone maintenance treatment outcomes","volume":"27","author":"B Brands","year":"2008","journal-title":"J Addict Dis"},{"issue":"10","key":"pone.0232086.ref043","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addbeh.2014.05.007","article-title":"Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study","volume":"39","author":"A Bukten","year":"2014","journal-title":"Addict Behav"},{"issue":"8","key":"pone.0232086.ref044","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"L Burns","year":"2009","journal-title":"Addiction"},{"key":"pone.0232086.ref045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2014.09.776","article-title":"Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study","volume":"145","author":"X Cao","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0232086.ref046","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2012.03.002","article-title":"Predictors of methadone program non-retention for opioid analgesic dependent patients","volume":"44","author":"J Cox","year":"2013","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"pone.0232086.ref047","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"CO Cunningham","year":"2013","journal-title":"J Addict Med"},{"issue":"1","key":"pone.0232086.ref048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5055\/jom.2007.0036","article-title":"Patterns of illicit drug use and retention in a methadone program: a longitudinal study","volume":"3","author":"I Davstad","year":"2007","journal-title":"J Opioid Manag"},{"key":"pone.0232086.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.06.004","article-title":"A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders","volume":"80","author":"P Dayal","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0232086.ref050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02287327","article-title":"Retention in publicly funded methadone maintenance treatment in two Western States","volume":"32","author":"D Deck","year":"2005","journal-title":"J Behav Health Serv Res"},{"key":"pone.0232086.ref051","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugpo.2017.05.014","article-title":"Retention in medication-assisted treatment programs in Ukraine\u2014Identifying factors contributing to a continuing HIV epidemic","volume":"48","author":"K Dumchev","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"pone.0232086.ref052","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","article-title":"Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada","volume":"9","author":"JK Eibl","year":"2015","journal-title":"J Addict Med"},{"issue":"1","key":"pone.0232086.ref053","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-017-0134-5","article-title":"The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario","volume":"14","author":"AM Franklyn","year":"2017","journal-title":"Harm Reduct J"},{"issue":"2","key":"pone.0232086.ref054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0740-5472(01)00185-4","article-title":"Transportation and retention in outpatient drug abuse treatment programs","volume":"21","author":"PD Friedmann","year":"2001","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"pone.0232086.ref055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","article-title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance","volume":"35","author":"G Gerra","year":"2011","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"3","key":"pone.0232086.ref056","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jsat.2013.10.004","article-title":"Leaving buprenorphine treatment: patients\u2019 reasons for cessation of care","volume":"46","author":"J Gryczynski","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"pone.0232086.ref057","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1360-0443.2012.03859.x","article-title":"Misconceptions predict dropout and poor adherence prospectively among newly admitted first\u2010time methadone maintenance treatment clients in Guangzhou, China","volume":"107","author":"J Gu","year":"2012","journal-title":"Addiction"},{"issue":"1\u20132","key":"pone.0232086.ref058","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2012.12.008","article-title":"Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes","volume":"131","author":"MS Haddad","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"pone.0232086.ref059","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-244X-12-238","article-title":"Methadone treatments in a Swiss region, 2001\u20132008: a registry-based analysis","volume":"12","author":"T Huissoud","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"2","key":"pone.0232086.ref060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/23288604.2018.1440347","article-title":"Association between user fees and dropout from methdone maintenance therapy: results of a cohort study in Vietnam","volume":"4","author":"B Johns","year":"2018","journal-title":"Health Systems and Reform"},{"issue":"1","key":"pone.0232086.ref061","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2006.10399832","article-title":"Predicting treatment retention with a brief \"Opinions About Methadone\" scale","volume":"38","author":"DJ Kayman","year":"2006","journal-title":"J Psychoactive Drugs"},{"issue":"2\u20133","key":"pone.0232086.ref062","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2011.01.008","article-title":"Predictors of methadone treatment retention from a multi-site study: a survival analysis","volume":"117","author":"SMO Kelly","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0232086.ref063","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/cid\/ciu382","article-title":"Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study","volume":"59","author":"BH Lambdin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"pone.0232086.ref064","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.addbeh.2018.10.046","article-title":"Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients","volume":"90","author":"DM Ledgerwood","year":"2019","journal-title":"Addict Behav"},{"issue":"1\u20132","key":"pone.0232086.ref065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10826084.2012.749411","article-title":"Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan","volume":"48","author":"H-C Lin","year":"2013","journal-title":"Subst Use Misuse"},{"issue":"4","key":"pone.0232086.ref066","article-title":"Factors associated with methadone treatment duration: A Cox regression analysis","volume":"10","author":"CK Lin","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"pone.0232086.ref067","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/09540121.2016.1259452","article-title":"Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China","volume":"29","author":"D Liu","year":"2017","journal-title":"AIDS Care"},{"issue":"6","key":"pone.0232086.ref068","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/ajad.12553","article-title":"Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration","volume":"26","author":"A Manhapra","year":"2017","journal-title":"Am J Addict"},{"issue":"7","key":"pone.0232086.ref069","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/appi.ps.201700363","article-title":"Three-Year Retention in Buprenorphine Treatment for Opioid Use Disorder Among Privately Insured Adults","volume":"69","author":"A Manhapra","year":"2018","journal-title":"Psychiatric services (Washington, DC)"},{"key":"pone.0232086.ref070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.addbeh.2018.09.010","article-title":"Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder","volume":"89","author":"S Meshberg-Cohen","year":"2019","journal-title":"Addict Behav"},{"key":"pone.0232086.ref071","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention","volume":"57","author":"LB Monico","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"pone.0232086.ref072","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ajad.12896","article-title":"Long-Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine","volume":"28","author":"C Montalvo","year":"2019","journal-title":"Am J Addict"},{"issue":"6","key":"pone.0232086.ref073","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/00952990.2012.694516","article-title":"A national study of the retention of Irish opiate users in methadone substitution treatment","volume":"38","author":"L Mullen","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"6","key":"pone.0232086.ref074","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/aje\/kwp186","article-title":"Proportional hazards frailty models for recurrent methadone maintenance treatment","volume":"170","author":"B Nosyk","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pone.0232086.ref075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel","volume":"27","author":"E Peles","year":"2008","journal-title":"J Addict Dis"},{"key":"pone.0232086.ref076","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","article-title":"Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center","volume":"185","author":"E Peles","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0232086.ref077","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/10826084.2014.957769","article-title":"Psychological predictors of retention in a low-threshold methadone maintenance treatment for opioid addicts: a 1-year follow-up study","volume":"50","author":"M Perreault","year":"2015","journal-title":"Subst Use Misuse"},{"issue":"2\u20134","key":"pone.0232086.ref078","first-page":"37","article-title":"Determinants of retention in a Canadian low-threshold Methadone Maintenance Program","volume":"3","author":"M Perreault","year":"2005","journal-title":"Journal of Maintenance in the Addictions"},{"issue":"4","key":"pone.0232086.ref079","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment","volume":"29","author":"SL Proctor","year":"2015","journal-title":"Psychol Addict Behav"},{"issue":"7","key":"pone.0232086.ref080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1185\/03007995.2013.796284","article-title":"Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005\u20132011","volume":"29","author":"J Ren","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"pone.0232086.ref081","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12954-016-0124-z","article-title":"Retention in Georgia opioid substitution therapy program and associated factors","volume":"13","author":"E Ruadze","year":"2016","journal-title":"Harm Reduct J"},{"issue":"7","key":"pone.0232086.ref082","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","article-title":"Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population","volume":"55","author":"B Saloner","year":"2017","journal-title":"Med Care"},{"issue":"3","key":"pone.0232086.ref083","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2011.07.009","article-title":"Predictive factors for treatment retention in methadone programs in Indonesia","volume":"42","author":"R Sarasvita","year":"2012","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"pone.0232086.ref084","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","volume":"132","author":"ZH Schuman-Olivier","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"pone.0232086.ref085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ADT.0000000000000099","article-title":"Factors predictive of 1-year retention on methadone maintenance therapy program: A survival analysis study","volume":"16","author":"R Shakira","year":"2017","journal-title":"Addictive Disorders and Their Treatment"},{"issue":"5","key":"pone.0232086.ref086","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1060028017751913","article-title":"Treatment Persistence Among Insured Patients Newly Starting Buprenorphine\/Naloxone for Opioid Use Disorder","volume":"52","author":"N Shcherbakova","year":"2018","journal-title":"The Annals of pharmacotherapy"},{"issue":"12","key":"pone.0232086.ref087","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/add.14398","article-title":"High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis","volume":"113","author":"ME Socias","year":"2018","journal-title":"Addiction"},{"issue":"11","key":"pone.0232086.ref088","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"MD Stein","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"5","key":"pone.0232086.ref089","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.addbeh.2004.09.004","article-title":"Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence","volume":"30","author":"CJ Strike","year":"2005","journal-title":"Addict Behav"},{"issue":"2","key":"pone.0232086.ref090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.drugalcdep.2013.06.021","article-title":"Time to first treatment interruption in the Chinese methadone maintenance treatment programme","volume":"133","author":"SG Sullivan","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"pone.0232086.ref091","first-page":"19","article-title":"Predictors of retention and mortality among patients on methadone maintenance therapy","volume":"20","author":"J Teoh","year":"2017","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"5","key":"pone.0232086.ref092","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ADM.0b013e31829da05b","article-title":"A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi\u2019an","volume":"7","author":"X Wei","year":"2013","journal-title":"J Addict Med"},{"key":"pone.0232086.ref093","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in Office Based Opioid Treatment with buprenorphine","volume":"74","author":"ZMK Weinstein","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"pone.0232086.ref094","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7517-10-3","article-title":"Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China","volume":"10","author":"F Yang","year":"2013","journal-title":"Harm Reduct J"},{"issue":"10","key":"pone.0232086.ref095","doi-asserted-by":"crossref","first-page":"e0139942","DOI":"10.1371\/journal.pone.0139942","article-title":"Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China","volume":"10","author":"L Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"pone.0232086.ref096","doi-asserted-by":"crossref","first-page":"e0179009","DOI":"10.1371\/journal.pone.0179009","article-title":"Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment","volume":"12","author":"K Zhou","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0232086.ref097","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0000000000000263","article-title":"Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi\u2019an, China","volume":"11","author":"KNL Zhou","year":"2017","journal-title":"J Addict Med"},{"issue":"2","key":"pone.0232086.ref098","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1360-0443.2009.02754.x","article-title":"Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands","volume":"105","author":"P Blanken","year":"2010","journal-title":"Addiction"},{"issue":"8","key":"pone.0232086.ref099","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/add.14188","article-title":"The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom","volume":"113","author":"M Hickman","year":"2018","journal-title":"Addiction"},{"key":"pone.0232086.ref100","doi-asserted-by":"crossref","first-page":"c3172","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"J Kimber","year":"2010","journal-title":"Bmj"},{"key":"pone.0232086.ref101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2019.05.026","article-title":"Stress, craving and mood as predictors of early dropout from opioid agonist therapy","volume":"202","author":"LV Panlilio","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"pone.0232086.ref102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"L Platt","year":"2018","journal-title":"Addiction"},{"issue":"7","key":"pone.0232086.ref103","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/cid\/civ476","article-title":"The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs","volume":"61","author":"B Nosyk","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9719","key":"pone.0232086.ref104","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"BM Mathers","year":"2010","journal-title":"Lancet (London, England)"},{"key":"pone.0232086.ref105","doi-asserted-by":"crossref","first-page":"e5945","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"GJ MacArthur","year":"2012","journal-title":"Bmj"},{"issue":"1","key":"pone.0232086.ref106","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","article-title":"Cycling in and out of treatment; participation in methadone treatment in NSW, 1990\u20132002","volume":"81","author":"J Bell","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"pone.0232086.ref107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.12.009","article-title":"J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study","volume":"173","author":"G Cousins","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"pone.0232086.ref108","doi-asserted-by":"crossref","first-page":"e017453","DOI":"10.1136\/bmjopen-2017-017453","article-title":"Consensus validation of the POSAMINO (POtentially Serious Alcohol-Medication INteractions in Older adults) criteria","volume":"7","author":"AE Holton","year":"2017","journal-title":"BMJ open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T19:20:17Z","timestamp":1589484017000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232086"}},"subtitle":[],"editor":[{"given":"Carl A.","family":"Latkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":108,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232086","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]}}}